These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 5829942)
41. [Experience with the psychotherapy of ulcerative colitis]. Schaeffer G Dtsch Gesundheitsw; 1966 Mar; 21(9):391-6. PubMed ID: 5982023 [No Abstract] [Full Text] [Related]
42. [20 years of ulcerative colitis treatment. Retrospective study from the point of view of a medical clinic]. Fiedler H Z Gesamte Inn Med; 1980 Dec; 35(24):890-3. PubMed ID: 7222836 [TBL] [Abstract][Full Text] [Related]
43. [Dietary standards in ulcerative colitis]. KRIGUN S; SCHOR I Dia Med; 1959 Jun; 31(40):1063 passim. PubMed ID: 13672043 [No Abstract] [Full Text] [Related]
45. Addition of leukocytapheresis to steroid therapy: is it beneficial in recurrence of moderate-to-severe ulcerative colitis? Jo Y; Matsumoto T; Mibu R; Iida M Dis Colon Rectum; 2003 Oct; 46(10 Suppl):S3-9. PubMed ID: 14530652 [TBL] [Abstract][Full Text] [Related]
46. Autoimmune hemolytic anemia and positive Coombs test associated with ulcerative colitis. Giannadaki E; Potamianos S; Roussomoustakaki M; Kyriakou D; Fragkiadakis N; Manousos ON Am J Gastroenterol; 1997 Oct; 92(10):1872-4. PubMed ID: 9382055 [TBL] [Abstract][Full Text] [Related]
47. [Diagnostic and therapeutic problems in ulcerative colitis]. Wasiak M; Trauber-Bajszczak U; Kuczewska-Stanecka K Pol Merkur Lekarski; 1996 Sep; 1(3):193-4. PubMed ID: 9139787 [TBL] [Abstract][Full Text] [Related]
48. [Characteristics of the disorders of the T chain of the immune system in nonspecific ulcerative colitis and their significance in choosing effective therapy]. Shakhnazarov AA Ter Arkh; 1984; 56(2):106-8. PubMed ID: 6608803 [No Abstract] [Full Text] [Related]
49. Special diets in radiotherapy. Parry G Radiography; 1972 Mar; 38(447):61-5. PubMed ID: 5072059 [No Abstract] [Full Text] [Related]
50. Gambling aspects in medicine. 8. So, how good a punter are you? Castle WM Cent Afr J Med; 1969 Oct; 15(11):234-7. PubMed ID: 5356576 [No Abstract] [Full Text] [Related]
51. [Primary hyperlipemia: response to dietary restriction of carbohydrates and fats]. Brusco OJ Medicina (B Aires); 1967; 27(5):269-75. PubMed ID: 5619829 [No Abstract] [Full Text] [Related]
52. Bifidogenic growth stimulator for the treatment of active ulcerative colitis: a pilot study. Suzuki A; Mitsuyama K; Koga H; Tomiyasu N; Masuda J; Takaki K; Tsuruta O; Toyonaga A; Sata M Nutrition; 2006 Jan; 22(1):76-81. PubMed ID: 16226014 [TBL] [Abstract][Full Text] [Related]
53. Predicting the outcome of severe ulcerative colitis: development of a novel risk score to aid early selection of patients for second-line medical therapy or surgery. Ho GT; Mowat C; Goddard CJ; Fennell JM; Shah NB; Prescott RJ; Satsangi J Aliment Pharmacol Ther; 2004 May; 19(10):1079-87. PubMed ID: 15142197 [TBL] [Abstract][Full Text] [Related]
54. Quality of life in patients with active ulcerative colitis treated with selective leukocyte apheresis. Oxelmark L; Hillerås P; Dignass A; Mössner J; Schreiber S; Kruis W; Löfberg R Scand J Gastroenterol; 2007 Mar; 42(3):406-7. PubMed ID: 17354122 [No Abstract] [Full Text] [Related]
55. A critical appraisal of the dietary management of peptic ulcer and ulcerative colitis. WOLF S J Clin Nutr; 1954; 2(1):1-4. PubMed ID: 13152210 [No Abstract] [Full Text] [Related]
56. Centrifugal leukocytapheresis therapy for ulcerative colitis without concurrent corticosteroid administration. Okada H; Takenaka R; Hiraoka S; Makidono C; Hori S; Kato J; Okazaki H; Kawamoto H; Mizuno M; Shiratori Y Ther Apher Dial; 2006 Jun; 10(3):242-6. PubMed ID: 16817788 [TBL] [Abstract][Full Text] [Related]
57. A randomized, double-blind, sham-controlled study of granulocyte/monocyte apheresis for active ulcerative colitis. Sands BE; Sandborn WJ; Feagan B; Löfberg R; Hibi T; Wang T; Gustofson LM; Wong CJ; Vandervoort MK; Hanauer S; Gastroenterology; 2008 Aug; 135(2):400-9. PubMed ID: 18602921 [TBL] [Abstract][Full Text] [Related]
58. A new treatment for HCV-ulcerative colitis comorbidity intolerant to INF-alpha. Sawada K; Ohnishi K; Fukunaga K; Shimoyama T Am J Gastroenterol; 2003 Jan; 98(1):228-9. PubMed ID: 12526978 [No Abstract] [Full Text] [Related]
59. Efficacy of Lactobacillus GG in maintaining remission of ulcerative colitis. Zocco MA; dal Verme LZ; Cremonini F; Piscaglia AC; Nista EC; Candelli M; Novi M; Rigante D; Cazzato IA; Ojetti V; Armuzzi A; Gasbarrini G; Gasbarrini A Aliment Pharmacol Ther; 2006 Jun; 23(11):1567-74. PubMed ID: 16696804 [TBL] [Abstract][Full Text] [Related]
60. Low-molecular-weight heparin (enoxaparin) as adjuvant therapy in the treatment of active ulcerative colitis: a randomized, controlled, comparative study. Zezos P; Papaioannou G; Nikolaidis N; Patsiaoura K; Papageorgiou A; Vassiliadis T; Giouleme O; Evgenidis N Aliment Pharmacol Ther; 2006 May; 23(10):1443-53. PubMed ID: 16669959 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]